J&J



Ebitda Cambiamento Data
AbbVie USD 6.92B 258M 2024-12
Abbott USD 2.18B 486M 2025-03
Amgen USD 3.71B 265M 2024-12
AstraZeneca USD 5.08B 182M 2025-03
Baxter International USD 576M 116M 2024-12
Bayer EUR 1.67B 3.36B 2024-12
Becton, Dickinson and Co. USD 1.25B 339M 2024-12
Biogen USD 754.8M 7.2M 2024-12
Boston Scientific USD 1.36B 16M 2025-03
Bristol-Myers Squibb USD 4.9B 16M 2025-03
CONMED USD 39.5M 31M 2025-03
Cooper Companies USD 243.8M 45.6M 2025-01
Dexcom USD 305.3M 98M 2024-12
Edwards Lifesciences USD 411.3M 15.3M 2025-03
Eli Lilly USD 4.16B 2B 2025-03
Gilead Sciences USD 3.21B 651M 2024-12
GlaxoSmithKline GBP 3.14B 1.06B 2025-03
Globus Medical USD 145.33M 29.19M 2024-12
Hologic USD 326.4M 15.5M 2024-12
Indivior 72M 34M 2025-03
Insulet USD 130.8M 21.4M 2024-12
Integra LifeSciences USD 104.98M 43.09M 2024-12
Intuitive Surgical USD 581.5M 168M 2025-03
J&J USD 7.88B 1.76B 2025-03
Medtronic USD 2.44B 134M 2025-01
Merck USD 7.12B 1.06B 2024-12
Merit Medical Systems USD 73.31M 3.35M 2025-03
Novartis USD 5.19B 319M 2024-12
Pfizer USD 6.21B 1.5B 2025-03
Regeneron Pharmaceuticals USD 730.9M 324.8M 2025-03
Roche Holding CHF 12.68B 2.36B 2024-06
Sanofi EUR 2.86B 2.3B 2025-03
Stryker USD 1.93B 473M 2024-12
Tandem Diabetes Care USD -30183000 33.85M 2025-03
Teva Pharmaceutical Industries USD 261M 1.01B 2024-12
Vertex Pharmaceuticals USD 1.16B 24.5M 2024-12
Zimmer Biomet Holdings USD 709.4M 138.6M 2024-12
Zoetis USD 894M 145M 2024-12



J&J - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.